Skip to content
English
עברית
TRIAL-IN Pharma
  • Home
  • About Us
    • A word from our General Manager
    • About the Staff
    • FAQ
    • Media
    • Lectures to organizations and congresses
    • Digital Health
  • Our Service
    • Worldwide Innovative Cancer Drugs and Treatments
    • Access to Treatment Consultation and Support
    • Medical Tourism Services for Cancer Patients
  • New Treatments
    • Clinical Trials
    • Compassionate Drugs
    • Case Studies or Case Reports
    • Articles
  • Cancer Types
    • Cancer: What is Cancer?
    • Bladder Cancer
    • Breast Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • DIPG – Brain Stem Cancer
    • Gastric Cancer
    • Glioblastoma
    • Kidney Cancer
    • Liver Cancer >>
    • Cholangiocarcinoma
    • Lung Cancer >>
      • Non Small Cell Lung Cancer, NSCLC
      • Small Cell Lung Cancer, SCLC
      • Mesothelioma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Skin Cancer and Melanoma
    • Thyroid Cancer
  • Cancer Glossary
  • Contact Us
  • עברית
  • Toggle website search
Menu Close
  • Home
  • About Us
    • A word from our General Manager
    • About the Staff
    • FAQ
    • Media
    • Lectures to organizations and congresses
    • Digital Health
  • Our Service
    • Worldwide Innovative Cancer Drugs and Treatments
    • Access to Treatment Consultation and Support
    • Medical Tourism Services for Cancer Patients
  • New Treatments
    • Clinical Trials
    • Compassionate Drugs
    • Case Studies or Case Reports
    • Articles
  • Cancer Types
    • Cancer: What is Cancer?
    • Bladder Cancer
    • Breast Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • DIPG – Brain Stem Cancer
    • Gastric Cancer
    • Glioblastoma
    • Kidney Cancer
    • Liver Cancer >>
    • Cholangiocarcinoma
    • Lung Cancer >>
      • Non Small Cell Lung Cancer, NSCLC
      • Small Cell Lung Cancer, SCLC
      • Mesothelioma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Skin Cancer and Melanoma
    • Thyroid Cancer
  • Cancer Glossary
  • Contact Us
  • עברית
  • Toggle website search
Read more about the article An enormous progress in the treatment of metastatic Triple Negative Breast Cancer

An enormous progress in the treatment of metastatic Triple Negative Breast Cancer

  • Post author:iris
  • Post published:March 20, 2019
  • Post category:Breast Cancer/Clinical Trials

Triple Negative Breast Cancer, TNBC, is the most aggressive type of breast cancer. Once the disease becomes metastatic, life expectancy is around 12 to 15 months. Triple Negative Breast Cancer,…

Continue ReadingAn enormous progress in the treatment of metastatic Triple Negative Breast Cancer

General Info

  • About Us
  • A word from our General Manager
  • About the Staff
  • Media
  • FAQ
  • Terms of Use
  • Contact Us

Popular topics

Bladder Cancer Breast Cancer Cancer: What is Cancer? Case Studies or Case Reports Cervical Cancer Cholangiocarcinoma Clinical Trials Colon Cancer Colorectal Cancer Compassionate Drugs DIPG (brain stem cancer) Endometrial Cancer Esophageal Cancer Gastric Cancer Glioblastoma Head and Neck Cancer Kidney Cancer Liver Cancer Lung Cancer Mesothelioma Non Small Cell Lung Cancer, NSCLC Ovarian Cancer Pancreatic Cancer Prostate Cancer Sarcoma Skin Cancer and Melanoma Small Cell Lung Cancer, SCLC Thyroid Cancer

Contact Info

  • Improve therapeutic outcomes, prolong life and quality of life, is our main business. Feel comfortable to contact us for any request or clarification.
  • Phone:+44.2082.426.039Opens in your application
  • Email:contact@trial-in.comOpens in your application

Follow us on Facebook

Designed and built by WP4All